四逆汤联合单硝酸异山梨酯治疗变异性心绞痛的效果分析

2017-11-20 17:18谭明琴
中国当代医药 2017年29期
关键词:炎症反应细胞因子心功能

谭明琴

[摘要]目的 研究四逆汤联合单硝酸异山梨酯治疗变异性心绞痛的效果。方法 选择2014年6月~2017年4月在淄博矿业集团有限责任公司中心医院就诊的74例变异性心绞痛患者,采用随机数字表法分为联合组和对照组,各37例。联合组接受四逆汤联合单硝酸异山梨酯治疗,对照组接受单硝酸异山梨酯治疗。治疗过程中,观察两组的心绞痛发作频率及持续时间,治疗后2周,检测两组的心功能指标及血清细胞因子含量。结果 联合组的心绞痛发作频率显著少于对照组,每次发作的持续时间显著短于对照组,差异有统计学意义(P<0.05)。治疗后2周时,联合组的心功能指标CO、EF水平均显著高于对照组,差异有统计学意义(P<0.05);联合组血清中的TNF-α、IL-6、ICAM-1含量均显著低于对照组,差异有统计学意义(P<0.05)。结论 四逆汤联合单硝酸异山梨酯治疗变异性心绞痛能够减少心绞痛发作,改善心功能并抑制炎症反应。

[關键词]四逆汤;变异性心绞痛;心功能;炎症反应;细胞因子

[中图分类号] R541.4 [文献标识码] A [文章编号] 1674-4721(2017)10(b)-0121-03

[Abstract]Objective To study the efficacy of Sini Decoction combined with Isosorbide Mononitrate in the treatment of variant angina pectoris.Methods 74 patients with variant angina pectoris in the Central Hospital of Zibo Mining Group Co.,LTD. from June 2014 to April 2017 were selected and divided into the combination group and the control group by random number table method,37 cases in each group.The combination group was treated with Sini Decoction combined with Isosorbide Mononitrate,the control group was treated with Isosorbide Mononitrate.During the course of treatment,the frequency and duration of angina pectoris in the two groups were observed.2 weeks after treatment,cardiac function indexes and serum cytokines were determined in the two groups.Results The frequency of angina pectoris in the combined group was significantly less than that in the control group and the duration of each attack in the combined group was significantly shorter than that in the control group,with significant difference (P<0.05).After 2 weeks of treatment,cardiac function indexes CO,EF of the combination group was significantly higher than that of the control group,with significant difference (P<0.05);serum tumor necrosis factor alpha (TNF-α),interleukin -6 (IL-6),intercellular adhesion molecule -1 (ICAM-1) contents in the combination group was significantly lower than that in the control group,with significant difference (P<0.05).Conclusion Sini Decoction combined with Isosorbide Mononitrate in the treatment of variant angina pectoris can reduce angina pectoris,improve heart function and inhibit inflammatory reaction.

[Key words]Sini Decoction;Variant angina pectoris;Heart function;Inflammatory reaction;Cytokine

变异性心绞痛是心绞痛的特殊类型,在安静状态下会出现心绞痛发作及心电图ST段抬高,会增加急性心肌梗死的发生风险[1-5]。单硝酸异山梨酯是治疗稳定型心绞痛的常用药物,能够有效扩张冠脉、增加心肌血流,但治疗变异性心绞痛的效果并不理想[6-7]。中医理论认为心绞痛属于“胸痹”的范畴,痰浊血瘀、正气亏虚是常见的病机。四逆汤出自张仲景的《伤寒杂病论》,具有化痰活血、回阳救逆的作用[8]。本研究旨在探讨四逆汤联合单硝酸异山梨酯治疗变异性心绞痛的效果,现报道如下。

1资料与方法endprint

1.1一般资料

选择2014年6月~2017年4月在淄博矿业集团有限责任公司中心医院中医科就诊的74例变异性心绞痛患者,所有患者均符合变异性心绞痛的诊断标准且取得知情同意,排除既往有心肌梗死病史的患者、合并感染性疾病的患者。采用随机数字表法将入选患者分为联合组和对照组,各37例。联合组中,男性22例,女性15例;年龄38~58岁,平均(45.2±5.4)岁。对照组中,男性20例,女性17例;年龄36~59岁,平均(45.9±5.7)岁。两组的一般资料比较,差异无统计学意义(P>0.05),具有可比性。本研究经医院医学伦理委员会批准。

1.2治疗方法

两组患者均给予单硝酸异山梨酯治疗,方法如下:20 mg单硝酸异山梨酯(宜昌三峡制药有限公司,批号:20135A83)稀释于200 ml生理盐水中,静脉滴注,连续治疗2周。联合组在上述治疗的基础上给予四逆汤加减治疗,方法如下:炙甘草6 g、干姜9 g、附子10 g、枳壳10 g、陈皮10 g、丹参10 g、砂仁6 g、葛根30 g、玄胡30 g、川楝子10 g、瓜萎30 g、薤白10 g、桂枝10 g,水煎服,每日1剂,分2次服用,连续治疗2周。

1.3观察指标

1.3.1临床情况观察 观察患者治疗过程中心绞痛发作的频率及每次发作的持续时间。

1.3.2心功能指标 治疗后2周时,两组患者均采用GE公司的彩超仪(型号:Voluson E8)进行心脏彩色多普勒超声检查,检测心功能指标,具体包括心排出量(CO)、心脏射血分数(EF)。

1.3.3血清指标检测 治疗后2周时,采集两组患者的肘静脉血,离心分离血清并采用上海西唐生物公司的酶联免疫吸附试剂盒测定肿瘤坏死因子-α(TNF-α,货号F14054)、白细胞介素-6(IL-6,货号F14912)、細胞间黏附分子-1(ICAM-1,货号F12503)的含量。

1.4统计学方法

采用SPSS 20.0统计学软件对数据进行分析,计量资料以x±s表示,采用t检验,以P<0.05为差异有统计学意义。

2结果

2.1两组临床情况的比较

联合组的心绞痛发作频率显著少于对照组,每次发作的持续时间显著短于对照组,差异有统计学意义(P<0.05)(表1)。

2.2两组心功能指标的比较

治疗后2周时,联合组的心功能指标CO、EF水平均显著高于对照组,差异有统计学意义(P<0.05)(表2)。

2.3两组血清指标的比较

治疗后2周时,联合组血清中的TNF-α、IL-6、ICAM-1含量均显著低于对照组,差异有统计学意义(P<0.05)(表3)。

3讨论

四逆汤是具有化痰活血、回阳救逆作用的中药汤剂,能够针对心绞痛的中医病机发挥治疗作用。该方中附子具有回阳救逆、温肾暖脾的功效,干姜具有化痰滞及回阳通脉的功效,甘草能够和中益气,一方面缓附子、干姜之燥热,另一方面又助附子、干姜回阳救逆[9]。为了初步明确四逆汤联合单硝酸异山梨酯治疗变异性心绞痛的效果,本研究首先对临床症状进行观察,结果显示,联合组治疗后2周时的心绞痛发作频率显著少于对照组,每次发作的持续时间显著短于对照组,提示四逆汤联合单硝酸异山梨酯能够较单硝酸异山梨酯单药治疗更为有效地减少心绞痛发作。心绞痛反复发作会加重心肌缺血,影响心脏泵血功能[10-11]。本研究对两组患者的心功能指标进行了分析,结果显示,联合组治疗后2周时的CO、EF水平均显著高于对照组,提示四逆汤联合单硝酸异山梨酯能够较单硝酸异山梨酯单药治疗更为有效地改善心功能。

在冠心病心绞痛的病程进展过程中,炎症反应涉及冠状动脉粥样斑块形成及性质改变的各个环节[12-15]。TNF-α、IL-6、ICAM-1是介导炎症反应的重要细胞因子,TNF-α在炎症反应的早期发生改变,既能直接造成斑块性质改变,又能介导炎症反应级联激活[16-17];IL-6是具有多种生物学功能的细胞因子,参与炎症反应和免疫应答的调控[18-19];ICAM-1是一类黏附分子,介导炎症细胞在斑块内的浸润、聚集[20]。本研究通过分析血清中上述炎性因子的含量可知,联合组治疗后2周时血清中的TNF-α、IL-6、ICAM-1含量均显著低于对照组,提示四逆汤联合单硝酸异山梨酯能够较单硝酸异山梨酯单药治疗更为有效地抑制变异性心绞痛病程中的炎症反应,有利于稳定冠状动脉粥样硬化斑块的性质。

综上所述,四逆汤联合单硝酸异山梨酯治疗变异性心绞痛能够减少心绞痛发作,改善心功能并抑制炎症反应。

[参考文献]

[1]Kim HL,Lee SH,Kim J,et al.Incidence and risk factors associated with hospitalization for variant angina in Korea[J].Medicine (Baltimore),2016,95(13):e3237

[2]Zhang S,Yan H,Yu P,et al.Development of protocatechualdehyde proliposomes-based sustained-release pellets with improved bioavailability and desired pharmacokinetic behavior for angina chronotherapy[J].Eur J Pharm Sci,2016,10(93):341-350.

[3]武艳玲,张奇,杨琴,等.变异型心绞痛临床治疗一例[J].江苏实用心电学杂志,2016,25(4):257-260.endprint

[4]楊琴,张奇,王安才,等.变异型心绞痛的心电图特征[J].实用心电学杂志,2016,25(4):251-256.

[5]杨桂英,刘筱菲.平板运动试验诱发变异性心绞痛一例[J].江苏实用心电学杂志,2015,24(5):378-380.

[6]Akyildiz ZI.Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina[J].Cardiology,2015, 130(4):221-222.

[7]Wu M,Villano A,Russo G,et al.Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina[J].Cardiology,2015,130(4):201-206.

[8]徐丽,朱庆贵.四逆汤结合地尔硫卓治疗变异型心绞痛临床疗效[J].陕西中医,2017,38(1):14-15.

[9]黄贝莉.四逆汤在冠心病心绞痛患者中的应用观察[J].海峡药学,2016,28(9):118-119.

[10]Mygind ND,Michelsen MM,Pena A,et al.Coronary microvascular function and cardiovascular risk factors in women with angina pectorisand no obstructive coronary artery disease:the iPOWER study[J].J Am Heart Assoc,2016,5(3):e003064.

[11]Slavich M,Maranta F,Fumero A,et al.Long-term preservation of left ventricular systolic function in patients with refractory angina pectoris and inducible myocardial ischemia on optimal medical therapy[J].Am J Cardiol,2016, 117(10):1558-1561.

[12]Horváth Z,Csuka D,Vargova K,et al.Alternative complement pathway activation during invasive coronary procedures in acute myocardial infarction and stable angina pectoris[J].Clin Chim Acta,2016,463:138-144.

[13]Mostowik M,Siniarski A,Golebiowska-Wiatrak R,et al.Prolonged CRP increase after percutaneous coronary intervention is associated with high thrombin concentrations and low platelet′ response to clopidogrel in patients with stable angina[J].Adv Clin Exp Med,2015,24(6):979-985.

[14]Gin AL,Vergallo R,Minami Y,et al.Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy[J].Coron Artery Dis,2016,27(8):629-635.

[15]Neufcourt L,Assmann KE,Fezeu LK,et al.Prospective association between the dietary inflammatory index and cardiovascular diseases in the supplémentation en vitamines et minéraux antioxydants (SU.VI.MAX) cohort[J].J Am Heart Assoc,2016,5(3):e002735.

[16]Wu JJ,Guérin A,Sundaram M,et al.Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate[J].J Am Acad Dermatol,2017,76(1):81-90.

[17]Dopheide JF,Knopf P,Zeller GC,et al.Low IL-10/TNFα ratio in patients with coronary artery disease and reduced left ventricular ejection fraction with a poor prognosis after 10 years[J].Inflammation,2015,38(2):911-922.

[18]Caselli C,De Graaf MA,Lorenzoni V,et al.HDL cholesterol,leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain[J].Atherosclerosis,2015,241(1):55-61.

[19]Tang JN,Shen DL,Liu CL,et al.Plasma levels of C1q/TNF-related protein 1 and interleukin 6 in patients with acute coronary syndrome or stable angina pectoris[J].Am J Med Sci,2015,349(2):130-136.

[20]Jalaly L,Sharifi G,Faramarzi M,et al.Comparison of the effects of Crataegus oxyacantha extract,aerobic exercise and their combination on the serum levels of ICAM-1 and E-selectin in patients with stable angina pectoris[J].Daru,2015,23:54.endprint

猜你喜欢
炎症反应细胞因子心功能
冠心病合并心衰介入治疗后BNP水平及其对心功能的影响分析
参麦、参附注射液在老年慢性心功能不全治疗中的疗效观察
心脏再同步治疗慢性心衰对心律失常与心功能水平的影响
综合康复护理对改善老年慢性心力衰竭患者心功能的效果观察
益气扶正法在脓毒症患者中的治疗及对血清核因子—κB活性变化的影响研究
脓毒症的分子细胞学研究进展
右美托咪定对脓毒症患者围术期血浆中细胞因子的影响
中西医结合治疗重度烧伤脓毒症的效果研究
研究谷氨酰胺对严重脓毒症患者炎症反应以及免疫功能的影响
对付肿瘤的细胞因子疗法